BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 24195602)

  • 1. Biosafety of recombinant adeno-associated virus vectors.
    Dismuke DJ; Tenenbaum L; Samulski RJ
    Curr Gene Ther; 2013 Dec; 13(6):434-52. PubMed ID: 24195602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress with Recombinant Adeno-Associated Virus Vectors for Gene Therapy of Alpha-1 Antitrypsin Deficiency.
    Gruntman AM; Flotte TR
    Hum Gene Ther Methods; 2015 Jun; 26(3):77-81. PubMed ID: 26067712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the potential for AAV vector genotoxicity in a murine model.
    Li H; Malani N; Hamilton SR; Schlachterman A; Bussadori G; Edmonson SE; Shah R; Arruda VR; Mingozzi F; Wright JF; Bushman FD; High KA
    Blood; 2011 Mar; 117(12):3311-9. PubMed ID: 21106988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current limitations of gene therapy for rare pediatric diseases: Lessons learned from clinical experience with AAV vectors.
    Gardin A; Ronzitti G
    Arch Pediatr; 2023 Nov; 30(8S1):8S46-8S52. PubMed ID: 38043983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unlocking the potential of adeno-associated virus in neuroscience: a brief review.
    Minetti A
    Mol Biol Rep; 2024 Apr; 51(1):563. PubMed ID: 38647711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adeno-associated viruses for gene therapy - clinical implications and liver-related complications, a guide for hepatologists.
    Mücke MM; Fong S; Foster GR; Lillicrap D; Miesbach W; Zeuzem S
    J Hepatol; 2024 Feb; 80(2):352-361. PubMed ID: 37890721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of appropriate non-clinical animal models to ensure translatability of novel AAV-gene therapies to the clinic.
    Singh M; Brooks A; Toofan P; McLuckie K
    Gene Ther; 2024 Jan; 31(1-2):56-63. PubMed ID: 37612361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adeno-associated virus as a delivery vector for gene therapy of human diseases.
    Wang JH; Gessler DJ; Zhan W; Gallagher TL; Gao G
    Signal Transduct Target Ther; 2024 Apr; 9(1):78. PubMed ID: 38565561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of AAV-Mediated Gene Therapy Approaches to Treat Skeletal Diseases.
    Lin C; Greenblatt MB; Gao G; Shim JH
    Hum Gene Ther; 2024 May; 35(9-10):317-328. PubMed ID: 38534217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evolution of heart gene delivery vectors.
    Wasala NB; Shin JH; Duan D
    J Gene Med; 2011 Oct; 13(10):557-65. PubMed ID: 21837689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons learned from lung and liver in-vivo gene therapy: implications for the future.
    van Haasteren J; Hyde SC; Gill DR
    Expert Opin Biol Ther; 2018 Sep; 18(9):959-972. PubMed ID: 30067117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral vectors for in vivo gene transfer in Parkinson's disease: properties and clinical grade production.
    Mandel RJ; Burger C; Snyder RO
    Exp Neurol; 2008 Jan; 209(1):58-71. PubMed ID: 17916354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug product Formulation and Fill/Finish Manufacturing Process Considerations for AAV-Based Genomic Medicines.
    Som M; Gikanga B; Kanapuram V; Yadav S
    J Pharm Sci; 2024 Jul; 113(7):1711-1725. PubMed ID: 38570073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of Adeno-associated virus-based vector-mediated gene therapy-impact of vector dose.
    Maurya S; Sarangi P; Jayandharan GR
    Cancer Gene Ther; 2022 Oct; 29(10):1305-1306. PubMed ID: 35027711
    [No Abstract]   [Full Text] [Related]  

  • 15. Recent developments in gene therapy research in India.
    Selot R; Ghosh A
    J Biosci; 2024; 49():. PubMed ID: 38384245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy: design and prospects for craniofacial regeneration.
    Scheller EL; Krebsbach PH
    J Dent Res; 2009 Jul; 88(7):585-96. PubMed ID: 19641145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards Clinical Implementation of Adeno-Associated Virus (AAV) Vectors for Cancer Gene Therapy: Current Status and Future Perspectives.
    Hacker UT; Bentler M; Kaniowska D; Morgan M; Büning H
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32674264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene Therapy.
    Thorne B; Takeya R; Vitelli F; Swanson X
    Adv Biochem Eng Biotechnol; 2018; 165():351-399. PubMed ID: 28289769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Gene Therapy Resource Program: A Decade of Dedication to Translational Research by the National Heart, Lung, and Blood Institute.
    Flotte TR; Daniels E; Benson J; Bevett-Rose JM; Cornetta K; Diggins M; Johnston J; Sepelak S; van der Loo JCM; Wilson JM; McDonald CL
    Hum Gene Ther Clin Dev; 2017 Dec; 28(4):178-186. PubMed ID: 29130351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in Respiratory Gene Therapy.
    McLachlan G; Alton EWFW; Boyd AC; Clarke NK; Davies JC; Gill DR; Griesenbach U; Hickmott JW; Hyde SC; Miah KM; Molina CJ
    Hum Gene Ther; 2022 Sep; 33(17-18):893-912. PubMed ID: 36074947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.